用现实世界的证据解决ANCA相关血管炎的临床挑战
1Department of Medicine, University of Cambridge and Addenbrooke's Hospital, Cambridge, UK.
Rheumatology (Oxford, England)
|November 3, 2025
概括
阿瓦科班是一种C5aR1抗剂,可帮助患有ANCA相关血管炎 (AAV) 的患者实现持续缓解,并减少葡萄糖皮质激素 (GC) 的使用. 这种治疗有望改善功能和管理耐火性AAV.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 与ANCA相关的血管炎 (AAV) 管理在实现快速,持续的缓解和降低葡萄糖皮质醇 (GC) 毒性方面面临挑战.
- 目前的治疗需要优化,以获得更好的患者结果和减少副作用.
研究的目的:
- 评估阿瓦科潘的疗效,补充5a受体1 (C5aR1) 抗剂,作为AAV管理中的辅助疗法.
- 评估阿瓦科潘对缓解率,GC暴露和功能恢复的影响.
主要方法:
- 临床试验数据的分析,涉及AAV患者接受Rituximab或Cyclophosphamide治疗,有或没有avacopan.
- 包含关于阿瓦科班用于GC替代和特定AAV患者亚组的真实世界的证据.
主要成果:
- 长达一年的辅助阿瓦科班治疗导致持续的AAV缓解和显著的GC减少.
- 阿瓦科潘改善了功能恢复,特别是在急性损伤的患者中.
- 现实世界的数据支持阿瓦科班作为一种GC替代药物,用于毒性和耐火性AAV,包括快速进展的淋巴结膜炎和肺出血.
结论:
- 阿瓦科潘在实现和维持AAV患者的缓解方面具有显著的好处,同时减少GC暴露.
- 阿瓦科潘为改善脏结果和管理复杂的AAV病例提供了一个有前途的治疗选择.
- 需要进一步的研究来探索阿瓦科潘的长期疗效及其在不同患者群体中的使用.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.6K
09:16Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
7.3K
相关概念视频
01:26Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
343
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
343
01:21Rheumatic Heart Disease III: Medical Management
277
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
277
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
470
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
470
01:23Atherosclerosis IV: Nursing Management
357
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
357
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
452
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
452